Pruritus severity in patients with psoriasis is not correlated with psoriasis disease severity - 16/01/14
Doi : 10.1016/j.jaad.2013.09.030
David Roblin, MD, FRCP a, ⁎ 
, Ro Wickramasinghe, PhD, MBA a, Gil Yosipovitch, MD b
, Ro Wickramasinghe, PhD, MBA a, Gil Yosipovitch, MD b a Creabilis Ltd, Canterbury, United Kingdom
b Department of Dermatology and Itch Center, Temple University School of Medicine, Philadelphia, Pennsylvania
∗Correspondence to: David Roblin, MD, FRCP, Creabilis Ltd, 6 Denne Hill Business Center, Canterbury, CT4 6HD, United Kingdom
| Supported by Creabilis Ltd. |
|
| Disclosures: Dr Roblin and Dr Wickramasinghe are employees of Creabilis Ltd. Dr Yosipovitch has consultant roles with Biogen Idec, GlaxoSmithKline, Mitsubishi, Regeneron, Leo Pharma, Cosmoderm, Dr Reddy's Laboratories, Brickell Biotech, Procter and Gamble, Creabilis Ltd, and Dignity Sciences. He has also received grant support or been a principal investigator in studies performed by GlaxoSmithKline, LEO Foundation, Mitsubishi, and Cosmoderm. |
© 2013
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 70 - N° 2
P. 390-391 - février 2014 Retour au numéro
Article précédent
- Retronychia in children, adolescents, and young adults: A case series
- Bianca Maria Piraccini, Bertrand Richert, David A. de Berker, Vera Tengattini, Paola Sgubbi, Annalisa Patrizi, Caterina Stinchi, Francesco Savoia
- Treatment of erythropoietic protoporphyria with the oral sorbent colestipol: A proof-of-concept clinical trial
- Peter V. Tishler, Bernard Rosner
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?